974 results on '"Sayer, G."'
Search Results
2. Outcomes Comparison of Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock with Acute Decompensated Heart Failure versus Acute Myocardial Infarction
3. History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)
4. Heart Transplantation in a Patient with Active Thyroid Cancer
5. Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock
6. Epicardial and Microvascular CAV are Associated with Restrictive Physiology After Heart Transplantation
7. CAV by PET/MBF Has Robust Negative Predictive Value for Development of Moderate to Severe CAV
8. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed
9. Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
10. Microcirculatory Dysfunction in Cardiogenic Shock
11. Should Living Alone be an Absolute Contraindication to HeartMate 3 Implantation: A Single Center Experience
12. Molecular Microscope (MMDx) Results in the Sensitized Heart Transplant Recipient
13. CAV Trajectories Among Patients with No or Mild CAV at 10 Years Post-Transplant
14. Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results
15. Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?
16. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope
17. Regional Variation and One-Year Outcomes of Heart Transplantation from Donation After Circulatory Death Donors in the United States
18. Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
19. Serial Assessment of MBFR Identifies Heart Transplant Recipients with an Increased Risk of Mortality
20. Omental Wrapping for Refractory Driveline Infection After HeartMate 3 Implantation
21. Sodium Glucose Co-Transporter 2 Inhibitor Use in HeartMate 3 Patients
22. Molecular Microscope (MMDx) After COVID-19 Vaccination in Heart Transplant Recipients
23. Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation
24. Social Work Evaluation Domains Related to Caregiver Support and Mental Health are Strong Predictors of Risk of Readmission or Driveline Infection After HeartMate 3 (HM3)
25. CAV Grading by PET Provides Improved Risk Stratification Compared to CA
26. Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
27. Association of Sarcopenia, Obesity and Sarcopenic Obesity with Inflammation in Advanced Heart Failure
28. Myocardial Blood Flow Assessment with PET Improves Risk Stratification Among HT Recipients with CAV1
29. Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)
30. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope
31. Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls
32. Mechanism and Clinical Impact of Late Tricuspid Regurgitation in Patients with Heartmate 3
33. Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients
34. Cystatin C- Based Estimated Glomerular Filtration Rate: A Predictive Metric for Long-Term Heartmate 3 Survival
35. Heart Failure Hospitalizations are Associated with Changes in Gut and Oral Microbiome
36. Cystatin C-Based Estimated Glomerular Filtration Rate is Independently Associated with Long-Term Mortality in HeartMate3 Patients
37. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients
38. Surgical Interventions for Accumulation of Biodebris Causing Outflow Graft Obstruction and Thrombosis Following HeartMate 3
39. Microvascular Responses to Donor Specific HLA Antibodies in Heart Transplantation. Sidestream Dark Field Imaging Results
40. Increased Incidence of Stroke After Heart Transplant in the New Allocation System Era
41. Implantable Pulmonary Artery Pressure Sensor Monitoring in a Heart Transplant Recipient
42. Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
43. Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock
44. "We Haven't Even Gotten Through This Horror Show, and Now There's Another Horror Show:" The Simultaneous Impact of COVID-19 and an Electronic Health Record Transition
45. (280) Comparison of Two Commercially Available Donor-Derived Cell-Free DNA Assays for Surveillance of Rejection in Heart Transplant Recipients
46. (230) The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study
47. (793) Validation of the Heartmate 3 Survival Risk Score in a Large Left Ventricular Assist Device Center
48. (1029) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease
49. (288) Preoperative Left Ventricular Diastolic Dimension Index Predicts Outcomes after Heartmate 3 Implantation
50. (4) Comparing Long-Term Survival and Readmissions Between Heartmate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.